Definium Therapeutics, Inc. (DFTX)
DFTX price $35.44 +0.35 +1.00%
- Ticker
- DFTX
- Price
- $35.44
- Change
- +0.35 +1.00%
- Market cap
- $4.76B
- P/E
- -10.20
- Forward P/E
- 32.16
- Sector
- Healthcare
- Industry
- Biotechnology
- Stocklytics score
- 70
Definium Therapeutics, Inc. operates as a clinical-stage biopharmaceutical firm dedicated to developing innovative therapeutic solutions for various brain health and neurological disorders. Its pipeline features key experimental drug candidates like MM120, which is currently undergoing Phase 3 clinical trials for generalized anxiety disorder (GAD) and attention deficit hyperactivity disorder (ADHD). Another…